125 related articles for article (PubMed ID: 7672800)
21. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
[TBL] [Abstract][Full Text] [Related]
22. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
Kelliher MA; Seldin DC; Leder P
EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
[TBL] [Abstract][Full Text] [Related]
23. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
24. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
25. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
[TBL] [Abstract][Full Text] [Related]
26. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
[TBL] [Abstract][Full Text] [Related]
27. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
[TBL] [Abstract][Full Text] [Related]
28. SCL gene in human tumors.
Rockman S; Begley CG; Kannourakis G; Mann GJ; Dobrovic AN; Kefford RF; McGrath K
Leukemia; 1992 Jul; 6(7):623-5. PubMed ID: 1625484
[TBL] [Abstract][Full Text] [Related]
29. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay.
Chen X; Pan Q; Stow P; Behm FG; Goorha R; Pui CH; Neale GA
Leukemia; 2001 Jan; 15(1):166-70. PubMed ID: 11243385
[TBL] [Abstract][Full Text] [Related]
30. The pufferfish SLP-1 gene, a new member of the SCL/TAL-1 family of transcription factors.
Göttgens B; Gilbert JG; Barton LM; Aparicio S; Hawker K; Mistry S; Vaudin M; King A; Bentley D; Elgar G; Green AR
Genomics; 1998 Feb; 48(1):52-62. PubMed ID: 9503016
[TBL] [Abstract][Full Text] [Related]
31. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
Barton LM; Göttgens B; Green AR
Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
[No Abstract] [Full Text] [Related]
32. SIL/TAL1 recombination in adult T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma.
Kwong YL; Chan D; Liang R
Cancer Genet Cytogenet; 1995 Dec; 85(2):159-60. PubMed ID: 8548743
[No Abstract] [Full Text] [Related]
33. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.
Anderegg B; Horstmann M; Ernst M; Kabisch H
Pediatr Hematol Oncol; 1997; 14(4):349-58. PubMed ID: 9211539
[TBL] [Abstract][Full Text] [Related]
34. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
Breit TM; Wolvers-Tettero IL; van Dongen JJ
Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
[TBL] [Abstract][Full Text] [Related]
35. The leukemic oncogene tal-2 is expressed in the developing mouse brain.
Mori S; Sugawara S; Kikuchi T; Tanji M; Narumi O; Stoykova A; Nishikawa SI; Yokota Y
Brain Res Mol Brain Res; 1999 Feb; 64(2):199-210. PubMed ID: 9931488
[TBL] [Abstract][Full Text] [Related]
36. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
[TBL] [Abstract][Full Text] [Related]
37. Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain.
Bernard M; Smit L; Macintyre E; Matthieu-Mahul D; Pulford K
Blood; 1995 Jun; 85(11):3356-7. PubMed ID: 7756670
[No Abstract] [Full Text] [Related]
38. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
39. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
[TBL] [Abstract][Full Text] [Related]
40. The SCL gene: from case report to critical hematopoietic regulator.
Begley CG; Green AR
Blood; 1999 May; 93(9):2760-70. PubMed ID: 10216069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
